English EN Spanish ES French FR Chinese (Simplified) ZH-CN
Print Friendly, PDF & Email

NCT/Study#

NCT04904276 /

O-FOSTA-901 (Forte)

Observational Study Of Fostamatinib As Second Line Therapy In Adult Patients With Immune Thrombocytopenia (ITP) And Insufficient Response To A Prior Therapy

DISEASE GROUP:
ITP
current phase:
N/A
STUDY STATUS:
Accepting Patients
Location:
Little Silver, NJ
For More information: